(19)
(11) EP 2 041 159 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.02.2012 Bulletin 2012/08

(45) Mention of the grant of the patent:
28.09.2011 Bulletin 2011/39

(21) Application number: 07733767.3

(22) Date of filing: 21.06.2007
(51) International Patent Classification (IPC): 
C07K 5/08(2006.01)
A61P 31/00(2006.01)
 A61K 38/06(2006.01)
(86) International application number:
PCT/GB2007/050346
(87) International publication number:
WO 2007/148135 (27.12.2007 Gazette 2007/52)

(54)

MACROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS

MAKROZYKLISCHE VERBINDUNGEN ALS ANTIVIRALE MITTEL

COMPOSES MACROCYCLIQUES EN TANT QU'AGENTS ANTIVIRAUX

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 23.06.2006 GB 0612423

(43) Date of publication of application:
01.04.2009 Bulletin 2009/14

(73) Proprietor: Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L.
00189 Roma (RM) (IT)

(72) Inventors:
  • CRESCENZI, Benedetta
    00040 Pomezia (Rome) (IT)
  • DONGHI, Monica
    00040 Pomezia (Rome) (IT)
  • FERRARA, Marco
    00040 Pomezia (Rome) (IT)
  • GARDELLI, Cristina
    00040 Pomezia (Rome) (IT)
  • HARPER, Steven
    00040 Pomezia (Rome) (IT)
  • KOCH, Uwe
    00040 Pomezia (Rome) (IT)
  • ROWLEY, Michael
    00040 Pomezia (Rome) (IT)
  • SUMMA, Vincenzo
    00040 Pomezia (Rome) (IT)

(74) Representative: Rollins, Anthony John 
Merck & Co., Inc. Hertford Road Hoddesdon,
Hertfordshire, EN11 9BU
Hertfordshire, EN11 9BU (GB)


(56) References cited: : 
WO-A-2005/070955
WO-A-2007/015787
 WO-A-2006/119061
WO-A-2007/016441
   
  • GOUDREAU N ET AL: "The Therapeutic Potential of NS3 Protease Inhibitors in HCV Infection" EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, vol. 14, no. 9, 2005, pages 1129-1144, XP003005098 ISSN: 1354-3784
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).